COLL vs LIN · P/E 17, rev $181.9M vs P/E 34, rev $33.99B
Collegium Pharmaceutical Inc (COLL) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the COLL and LIN stock pages for the full models.
Not investment advice.